1. China Stocks

  2. •

    Health technology

  3. •

    Biotechnology
EVOPOINT BIOSCIENCES CO LTD

EVOPOINT BIOSCIENCES CO LTD

SSSE:688837
39.19
CNY
+1.48
(+3.92%)
-0.05EPS
EVOPOINT BIOSCIENCES CO LTD
SSE:688837
(Shanghai Stock Exchange)

Recent

price

39.19

P/E

ratio

- -

div

yld

- -

ROIC.AI

2022
2023
2024
2025
CNY
0.06
- -
- -
2.54
Revenue per Share
-1.42
-1.25
-1.05
0.55
Basic EPS, GAAP
-1.78
-1.35
-1.09
0.31
Free Cash Flow per Basic Share
0.02
0.04
0.04
0.07
Dividend per Share
1.41
1.7
0.98
1.91
Book Value per Share
1.38
1.67
0.96
1.88
Tangible Book Value per Share
326
342
368
368
Basic Weighted Avg Shares
20
- -
- -
935
Sales/Revenue/Turnover
-2,645.69
- -
- -
22.75
Operating Margin (%)
15
18
26
40
Depreciation Expense
-463
-427
-386
203
Net Income, GAAP
- -
- -
- -
31.4
Effective Tax Rate (%)
-2,372.47
- -
- -
21.66
Profit Margin (%)
276
361
116
603
Working Capital
286
345
398
728
LT Debt
459
579
359
703
Total Equity
- -
- -
- -
19.16
Return on Invested Capital (%)
- -
- -
- -
17.64
Return on Capital (%)
- -
-82.22
-82.26
38.13
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

CNY

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
95.58%
Free Cash Flow
- -
- -
-128.95%
Net Income, GAAP
- -
- -
-152.48%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
47.39%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
935
2026
4
172
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-1.05
2025
-0.23
-0.63
- -
- -
0.55
2026
-0.34
-0.05
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.04
2025
- -
- -
- -
- -
0.07
2026
- -
- -
- -
- -
- -
Similar Companies
Moderna, Inc. (NASDAQ:MRNA)
Amgen Inc. (NASDAQ:AMGN)
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Novavax, Inc. (NASDAQ:NVAX)
10x Genomics, Inc. (NASDAQ:TXG)
Business
Evopoint Bioscience Co., Ltd. operates as a biopharmaceutical company. It produces inhibitors, diagnostic reagents, and other products. The company was founded by Mei Jie Le and Hong Han Hu on May 17, 2017 and is headquartered in Suzhou, China.